Download PDF Everolimus-induced somatostatin receptor overexpression in a rectal neuroendocrine tumor patient may promote somatostatin receptor-guided radionuclide therapy (peptide receptor radiotherapy) as an additional treatment option  This is a temporary file and hence do not link it from a website, instead link the URL of this page if you wish to link the PDF file. To read this article you will require Adobe© Acrobat Reader, if you do not have this installed you can download it from here Support open access Recommend
 | |
|